Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons

Diabetologia

Volumn 54, Issue 6, 2011, Pages 1360-1367

  Van Hoek, M ^a   Van Herpt, T W ^a,b   Dehghan, A ^a   Hofman, A ^a   Lieverse, A G ^b   Van Duijn, C M ^a   Witteman, J C M ^a   Sijbrands, E J G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MÁXIMA MEDICAL CENTER   (Netherlands)

Author keywords

APOC3; BMI; Polymorphism; Type 1 diabetes; Type 2 diabetes

Indexed keywords

INSULIN; ANTIDIABETIC AGENT; APOLIPOPROTEIN C3;

AGED; APOC3 GENE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ALLELE; BODY WEIGHT; CASE CONTROL STUDY; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; NETHERLANDS; PATHOPHYSIOLOGY; PROMOTER REGION; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEIN C-III; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS; THINNESS;

EID: 80052538156     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2092-x     Document Type: Article

References (38)

1. Kahn CR (1994) Banting lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43:1066-1084
2. Bray GA (1996) Health hazards of obesity. Endocrinol Metab Clin North Am 25:907-919
3. Seidell JC (1997) Time trends in obesity: an epidemiological perspective. Horm Metab Res 29:155-158
4. Garcia-Estevez DA, Araujo-Vilar D, Saavedra-Gonzalez A, Fiestras-Janeiro G, Cabezas-Cerrato J (2002) Glucose metabolism in lean patients with mild type 2 diabetes mellitus: evidence for insulin-sensitive and insulin-resistant variants. Metabolism 51:1047-1052
5. Van Haeften TW, Van Maarschalkerweerd WW, Gerich JE, Van der Veen EA (1991) Decreased insulin secretory capacity and normal pancreatic B-cell glucose sensitivity in non-obese patients with NIDDM. Eur J Clin Invest 21:168-174
6. Alvarsson M, Wajngot A, Cerasi E, Efendic S (2005) K-value and low insulin secretion in a non-obese white population: predicted glucose tolerance after 25 years. Diabetologia 48:2262-2268 (Pubitemid 41618916)
7. Arner P, Pollare T, Lithell H (1991) Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects. Diabetologia 34:483-487
8. Poulsen P, Levin K, Petersen I, Christensen K, Beck-Nielsen H, Vaag A (2005) Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins. Diabetes 54:275-283 (Pubitemid 40105123)
9. Mills GW, Avery PJ, McCarthy MI et al (2004) Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes. Diabetologia 47:732-738 (Pubitemid 38658376)
10. Lehtovirta M, Kaprio J, Forsblom C, Eriksson J, Tuomilehto J, Groop L (2000) Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins. Diabetologia 43:285-293 (Pubitemid 30163471)
11. Matsuda A, Kuzuya T (1994) Relationship between obesity and concordance rate for type 2 (non-insulin-dependent) diabetes mellitus among twins. Diabetes Res Clin Pract 26:137-143
12. Dahlquist G, Blom L, Tuvemo T, Nystrom L, Sandstrom A, Wall S (1989) The Swedish Childhood Diabetes Study-results from a nine year case register and a one year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders. Diabetologia 32:2-6 (Pubitemid 19061734)
13. Li H, Lindholm E, Almgren P et al (2001) Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 diabetes. J Clin Endocrinol Metab 86:574-582 (Pubitemid 32207461)
14. Hokanson JE, Kinney GL, Cheng S, Erlich HA, Kretowski A, Rewers M (2006) Susceptibility to type 1 diabetes is associated with ApoCIII gene haplotypes. Diabetes 55:834-838 (Pubitemid 43343244)
15. Jong MC, Hofker MH, Havekes LM (1999) Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol 19:472-484 (Pubitemid 29135144)
16. McGarry JD, Dobbins RL (1999) Fatty acids, lipotoxicity and insulin secretion. Diabetologia 42:128-138 (Pubitemid 29064233)
17. Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10
18. 2+-dependent beta cell death in type 1 diabetes. Proc Natl Acad Sci U S A 101:10090-10094
19. Dammerman M, Sandkuijl LA, Halaas JL, Chung W, Breslow JL (1993) An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc Natl Acad Sci U S A 90:4562-4566 (Pubitemid 23148945)
20. Li WW, Dammerman MM, Smith JD, Metzger S, Breslow JL, Leff T (1995) Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J Clin Invest 96:2601-2605
21. Hofman A, Breteler MM, van Duijn CM et al (2009) The Rotterdam study: 2010 objectives and design update. Eur J Epidemiol 24:553-572
22. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diab Care 20:1183-1197
23. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553 (Pubitemid 28319935)
24. WaterworthDM, Ribalta J, NicaudV,Dallongeville J,Humphries SE, Talmud P (1999) ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests. Circulation 99:1872-1877 (Pubitemid 29181417)
25. Waterworth DM, Talmud PJ, Humphries SE et al (2001) Variable effects of the APOC3-482 C>T variant on insulin, glucose and triglyceride concentrations in different ethnic groups. Diabetologia 44:245-248 (Pubitemid 32156211)
26. Waterworth DM, Talmud PJ, Luan J et al (2003) Variants in the APOC3 promoter insulin responsive element modulate insulin secretion and lipids in middle-aged men. Biochim Biophys Acta 1637:200-206 (Pubitemid 36407770)
27. Neel JV (1999) Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? 1962. Bull World Health Organ 77:694-703
28. Barker DJ, Eriksson JG, Forsen T, Osmond C (2002) Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 31:1235-1239 (Pubitemid 36204489)
29. Li H, Isomaa B, Taskinen MR, Groop L, Tuomi T (2000) Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diab Care 23:589-594 (Pubitemid 30321535)
30. Stalenhoef AF, Demacker PN, Lutterman JA, Van't Laar A (1982) Apolipoprotein C in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia. Diabetologia 22:489-491 (Pubitemid 12125966)
31. Florez H, Mendez A, Casanova-Romero P et al (2006) Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population. Atherosclerosis 188:134-141 (Pubitemid 44142528)
32. Boden G, Jadali F, White J et al (1991) Effects of fat on insulinstimulated carbohydrate metabolism in normal men. J Clin Invest 88:960-966
33. Boden G (1996) Fatty acids and insulin resistance. Diab Care 19:394-395
34. Goldberg IJ, Vanni-Reyes T, Ramakrishnan S, Holleran S, Ginsberg HN (2000) Circulating lipoprotein profiles are modulated differently by lipoprotein lipase in obese humans. J Cardiovasc Risk 7:41-47 (Pubitemid 30127573)
35. Ruge T, Sukonina V, Myrnas T, Lundgren M, Eriksson JW, Olivecrona G (2006) Lipoprotein lipase activity/mass ratio is higher in omental than in subcutaneous adipose tissue. Eur J Clin Invest 36:16-21
36. Pedersen SB, Jonler M, Richelsen B (1994) Characterization of regional and gender differences in glucocorticoid receptors and lipoprotein lipase activity in human adipose tissue. J Clin Endocrinol Metab 78:1354-1359 (Pubitemid 24181004)
37. Fried SK, Russell CD, Grauso NL, Brolin RE (1993) Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 92:2191-2198 (Pubitemid 23333523)
38. Irvine WJ, McCallum CJ, Gray RS, Duncan LJ (1977) Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents. Lancet 1:1025-1027 (Pubitemid 8088686)